A Neuroscientist’s Guide to Starting a Company
With Dana Watt
A PhD-trained neuroscientist talks about their path to becoming a partner in a VC firm and how venture investors think about investing in “deep tech” like neuroscience. She dives into neuroscience investing in particular and how to build a venture-backable neuroscience company, and highlights examples from her firm’s portfolio in neurotech. Neuroscience will remain difficult to invest in until meaningful biomarkers are developed, and meaningful biomarkers rely on better understanding of neuroscience disease mechanisms. We’re at an inflection point for a lot of enabling technologies that will drive this change, so I am bullish on the next 10-20 years of progress.